• Accueil
• 98 054 508 ds
• Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate. - Abstract - Europe PMC

Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate. - Abstract - Europe PMC

4.9 (371) · € 15.50 · En Stock

Europe PMC is an archive of life sciences journal literature.

Risk factors associated with hypophosphatemia in chronic Hepatitis

PDF) Comparable efficacy of tenofovir versus entecavir and

PDF) Incidence and Risk Factors of Hypophosphatemia in Patients

The role of tenofovir disoproxil fumarate for preventing vertical

Switching from entecavir to tenofovir disoproxil fumarate for

Tenofovir effect on the kidneys of HIV-infected patients: a double

Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low

Risk factors associated with hypophosphatemia in chronic Hepatitis

KASL clinical practice guidelines for management of chronic